Product Information
Triphendiol is a compound that has been shown to inhibit the growth of colorectal adenocarcinoma cells. It functions by triggering apoptosis, which is a process of programmed cell death, and it induces autophagy, a process in which cells degrade their own components. Triphendiol also inhibits migration and invasion of cervical cancer cells and has been shown to induce apoptosis in solid tumours. Triphendiol also prevents the growth of new blood vessels by inhibiting the production of two proteins that are involved in angiogenesis (growth of new blood vessels from pre-existing ones). The hydroxyl group on the triphendiol molecule interacts with the mitochondrial membrane potential, leading to apoptosis. This drug may be useful for diagnosis purposes due to its ability to cause apoptotic effects in tissue samples. After administration, triphendiol is excreted as metabolites into urine samples.
